Precision Neuropeptide Infusion
NeuroScience Institute on Addiction Recovery
Infusion Clinic Experts, Addiction NeuroScientists, BioMedical Engineers & Molecular NeuroPhysiologists
Natural Neuroadaptive Epigenetic Neurotherapy
Dr. Jay Bouldin: Chief Clinical Addiction Neuroscientist, Principal Investigator, Product Inventor-Developer & Peer Review Publisher
IV NTR3 NEURO
Due Diligence: Reviews, Alignments & Match Verifications
US GOVERNMENT, FDA-IND, USPTO, FEDERAL NIH-NIDA RFA, D& B, DoD CAGE-NAICS, GRANTS.GOV, STATE LLC-501c3 BUSINESS REGISTRATION, CARRIER CONTRACT CREDENTIALING, ETHEREUM, FACEBOOK-META-MULTIVERSE-NFT, VENMO COPR, BA CORPORATE ZELLE, PAYPAL & AMAZON PARTNERSHIP VETTED BUSINESS
NPIs: 1467193623 & 1083355119
HIPAA CONFIDENTIALITY NOTICE:
This email message and any attachments are for the sole use of the intended recipient(s) and may contain proprietary, confidential, trade secret or privileged information. Any unauthorized review, use, disclosure or distribution is prohibited and may be a violation of law. If you are not the intended recipient or a person responsible for delivering this message to an intended recipient, please contact the sender by replying to this email and destroy all copies of the original message.
FDA-HIH-CMS-DOD-DARPA Registered & Cleared
GOV-SAM-SBIR: JAC6JJKYAF77JJ / DUN#:01-342-8223 / CAGE:8TT10 / NAICS:541611